No Evidence of Sensory Neuropathy in a Traditional Mouse Model of Idiopathic Parkinson’s Disease
Open Access
Abstract
Parkinson’s disease (PD) is the second-most common neurodegenerative disorder worldwide and is diagnosed based on motor impairments. Non-motor symptoms are also well-recognised in this disorder, and peripheral neuropathy is a frequent but poorly appreciated non-motor sign. Studying how central and peripheral sensory systems are affected can contribute to the development of targeted therapies and deepen our understanding of the pathophysiology of PD. Although the cause of sporadic PD is unknown, chronic exposure to the pesticide rotenone in humans increases the risk of developing the disease. Here, we aimed to investigate whether peripheral neuropathy is present in a traditional model of PD. Mice receiving intrastriatal rotenone showed greatly reduced dopamine terminals in the striatum and a reduction in tyrosine hydroxylase-positive neurons in the Substantia nigra pars compacta and developed progressive motor impairments in hindlimb stepping and rotarod but no change in spontaneous activity. Interestingly, repeated testing using gold-standard protocols showed no change in gut motility, a well-known non-motor symptom of PD. Importantly, we did not observe any change in heat, cold, or touch sensitivity, again based upon repeated testing with well-validated protocols that were statistically well powered. Therefore, this traditional model fails to replicate PD, and our data again reiterate the importance of the periphery to the disorder.Keywords
All Related Versions
Funding Information
- Estonian Research Council (PRG957)
This publication has 69 references indexed in Scilit:
- Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson DiseaseJAMA Neurology, 2022
- Inhibition of Spinal 5-HT3 Receptor and Spinal Dorsal Horn Neuronal Excitability Alleviates Hyperalgesia in a Rat Model of Parkinson’s DiseaseMolecular Neurobiology, 2022
- Rodent models for gait network disorders in Parkinson's disease – a translational perspectiveExperimental Neurology, 2022
- Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gelBrain and Behavior, 2021
- Peripheral neuropathy in Parkinson’s diseaseNeurological Sciences, 2020
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Unilateral lesion of the nigroestriatal pathway with 6-OHDA induced allodynia and hyperalgesia reverted by pramipexol in ratsEuropean Journal of Pharmacology, 2020
- Levodopa‐Induced Neuropathy: A Systematic ReviewMovement Disorders Clinical Practice, 2018
- Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson’s diseaseBrain Research, 2016
- Estimation of nuclear population from microtome sectionsThe Anatomical Record, 1946